Views: 0 Author: Site Editor Publish Time: 2026-09-03 Origin: Site
For medical device exporters targeting Africa in 2026, the regulatory landscape remains one of the most critical – and challenging – factors for market success. South Africa‘s SAHPRA, Nigeria‘s NAFDAC, Kenya‘s Pharmacy and Poisons Board, and Egypt‘s Egyptian Drug Authority each run separate device rules, and none of them recognises each other‘s approvals by default.
The Four Major Regulators
South Africa (SAHPRA): SAHPRA currently regulates devices primarily through establishment licensing rather than product registration. In 2026, SAHPRA is phasing in mandatory ISO 13485 certification for every establishment licence holder. In February 2026, SAHPRA issued the Medical Device Reliance Guideline, outlining pre-market and post-market regulatory review procedures based on the reliance principle.
Nigeria (NAFDAC): NAFDAC requires every device to go through its automated product administration system, with Class A devices reviewed within a maximum of 120 working days and Classes B through D within 240 working days. The Nigerian Senate is pushing to consolidate all NAFDAC-regulated products into a single Food, Medical Products and Other Regulated Products Act
Kenya (PPB): Kenya‘s PPB uses a four-tier risk classification aligned to IMDRF principles, with review routes ranging from a 6 to 12 month full evaluation down to 48-hour immediate registration for devices already cleared by at least three reference regulators.
Egypt (EDA): Egypt‘s EDA classifies under an EU MDR-aligned system through its MeDevice portal, with standard review running 4 to 10 months and a fast track for CE-marked or FDA-cleared devices. In a single February 2026 notice, Egypt rewrote six categories of its device dossier requirements.
Progress Towards Harmonisation
The African Medicines Agency still needs 24 more ratifications to become fully operational. However, WHO and AMA signed a framework cooperation agreement and 2026–2030 joint action plan in May 2026, aiming to streamline regulatory processes across the continent and reduce duplication. For now, a company launching a medical device must still navigate dozens of different regulatory systems across Africa
Practical Advice for Exporters
Given this complexity, medical exporters should:
Start with a core market – choose one country (South Africa, Nigeria, Kenya, or Egypt) for initial registration
Leverage reference approvals – devices cleared by FDA, CE, or WHO prequalification may qualify for faster track in some countries
Plan for multiple registrations – harmonisation will take years, if not a decade
Work with local experts – regulatory agents and one-stop service providers can significantly reduce time and cost
As industry experts note, understanding the regulatory requirements, company and product registration processes, and practical dossier preparation for each African country has become an essential skill for medical trade enterprises. Professional compliance support is no longer optional – it is a competitive necessity.
